1. Borchers AT, et al. “Mushrooms, tumors and immunity.” Proc Soc Exp Biol Med . 1999 Sep;221(4):281-93.

2. Katakoa K, et al. “Activation of macrophages by linear 1-3 beta D glucans, implications for the recognition of fungi by innate immunity.” J Biol Chem . 2002 Sep 27;277(39): 26825-31.

3. Camellini CM, et al. “Stuctural characterization of beta-glucans of Agaricus brasiliensis in different stages of fruiting body maturity and their use in nutraceutical products.” Biotechnol Let. 2005 Sep;27(17):1295-9.

4. Angeli JP, et al. “Protective effects of beta-glucan extracted from Agaricus brasiliensis against chemically induced DNA damage in human lymphocytes.” Cell Biol Toxicol . 2006 Jul;22(4):285-91

5. Pacheco-Sanchez M, et al. “A bioactive (1,3), (1,4) beta D glucan from Collybia dryophila and other mushrooms.” Mycologia. 2006 Mar-Apr;98(2):180-5.

6. Ng ML, Yap AT. “Inhibition of human colon cancer development by Lentinan from shiitake mushrooms (Lentinus edodes). J Altern Complement Med. 2002 Oct;8(5):581-9.

7. Ooi VE, Liu, F. “Immunomodulation and anti-cancer activity of polysaccharide-protein complexes.” Curr Med Chem . 2000 Jul;7(7):715-29.

8. Czop, J., and J. Kay. 1991. Isolation and characterisation of β-glucan receptors on humanmononuclear phagocytes. Journal of Experimental Medicine, 173, 1511-1520.

9. Hobbs Ch. 1995. Medicinal mushrooms: an exploitation of traditional, healing and culture. Santa Cruz, Botanica Press. p251.

10. Ooi V. E. C., and Liu F. 1999. A review of pharmacological activities of mushroom polysaccharides.International Journal of Medicinal Mushrooms, 1, 195-206.

11. Wasser S. P., and Weis A. L. 1999a. Medicinal properties of substances occurring in higher basidiomycete mushrooms: current perspectives (review). International Journal of Medicinal Mushrooms, 1, 31-62.

12. Katakoa K, et al. “Activation of macrophages by linear 1-3 beta D glucans, implications for the recognition of fungi by innate immunity.” J Biol Chem . 2002 Sep 27;277(39): 26825-31.

13. Ooi VE, Liu, F. “Immunomodulation and anti-cancer activity of polysaccharide-protein complexes.” Curr Med Chem. 2000 Jul;7(7):715-29.

14. Breeme. W. 1990. Nutritional and medicinal value of speciality mushrooms. Journal of Food Protection. 53, 883-894.

15. Borchers A. T., Stern J. S., and Hackman R. M. 1999. Mushrooms, tumours, and immunity.Proceedings of the Society for Experimental Biological Medicine, 221, 281-293.

16. T. Mizuno: Antitumor Active Substances of Mushroom Fungi, Based Science and Latest Technology on Mushroom, pp. 121-35(1991), Nohson Bunka Sha, Tokyo.

17. T. Mizuno: Food Function and Medicinal Effects of Mushroom Fungi, pp.1-170(1994), Laboratory of Biochemistry, Faculty of Agriculture, Shizuoka University, Shizuoka.

18. Chan WK, Lam DT, Law HK, Wong WT, Koo MW, Lau AS, Lau YL, Chan GC: Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy.

19. Wasser SP: Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 2002, 60(3):258-274.

20. Borchers AT, Keen CL, Gershwin ME: Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 2004, 229(5):393-406

21. Bohn J, BeMiller J: (1->3)-β-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydrate Polymers 1995, 28(1):3-14.

22. Rolin DB, Pfeffer PE, Osman SF, Szwergold BS, Kappler F, Benesi AJ: Structural studies of a phosphocholine substituted beta-(1,3);(1,6) macrocyclic glucan from 23. Bradyrhizobium japonicum USDA 110. Biochimica et biophysica acta 1992, 1116(3):215-225.

23. Jelsma J, Kreger DR: Ultrastructural observations on (1 leads to 3)-beta-D-glucan from fungal cell-walls. Carbohydrate research 1975, 43(1):200-203.

24. Borchers AT, et al. “Mushrooms, tumors and immunity.” Proc Soc Exp Biol Med . 1999 Sep;221(4):281-93.

25. Katakoa K, et al. “Activation of macrophages by linear 1-3 beta D glucans, implications for the recognition of fungi by innate immunity.” J Biol Chem. 2002 Sep 27;277(39): 26825-31.

26. amellini CM, et al. “Stuctural characterization of beta-glucans of Agaricus brasiliensis in different stages of fruiting body maturity and their use in nutraceutical products.” Biotechnol Let . 2005 Sep;27(17):1295-9.

27. Angeli JP, et al. “Protective effects of beta-glucan extracted from Agaricus brasiliensis against chemically induced DNA damage in human lymphocytes.” Cell Biol Toxicol2006 Jul;22(4):285-91.